Band 3 mutations, distal renal tubular acidosis, and Southeast Asian ovalocytosis  by Wrong, Oliver et al.
Kidney International, Vol. 62 (2002), pp. 10–19
PERSPECTIVES IN BASIC SCIENCE
Band 3 mutations, distal renal tubular acidosis, and Southeast
Asian ovalocytosis
OLIVER WRONG, LESLEY J. BRUCE, ROBERT J. UNWIN, ASHLEY M. TOYE, and
MICHAEL J.A. TANNER
Centre for Nephrology, Royal Free and University College Medical School, London, and Department of Biochemistry,
University of Bristol, Bristol, England, United Kingdom
Band 3 mutations, distal renal tubular acidosis, and Southeast tion had arisen by chance. However, over the years some
Asian ovalocytosis. Familial distal renal tubular acidosis (dRTA) textbooks have listed “elliptocytosis” among the many
and Southeast Asian ovalocytosis (SAO) may coexist in the same causes of secondary dRTA, a suggestion that at one timepatient. Both can originate in mutations of the anion-exchanger
seemed reasonable, because another red cell abnormal-1 gene (AE1), which codes for band 3, the bicarbonate/chloride
ity, sickle-cell disease, was found to be associated withexchanger in both the red cell membrane and the basolateral
membrane of the collecting tubule alpha-intercalated cell. defective renal excretion of acid [2], apparently through
Dominant dRTA is usually due to a mutation of the AE1 gene, the effect of sickled red cells in promoting sludging in the
which does not alter red cell morphology. SAO is caused by renal medullary microcirculation with consequent ische-an AE1 mutation that leads to a nine amino acid deletion of
mic renal tubular damage.red cell band 3, but by itself does not cause dRTA. Recent
Over the years, clinical anecdotes and occasional case-gene studies have shown that AE1 mutations are responsible
for autosomal recessive dRTA in several countries in Southeast reports [3, 4] have suggested that the association of dRTA
Asia; these patients may be homozygous for the mutation or and SAO is too frequent to be due to chance, but the
be compound heterozygotes of two different AE1 mutations, confusion between elliptocytosis and SAO has continuedone of which is usually the SAO mutation.
to cloud the issue. The distinction between these two
similar blood pictures is made clear in Figure 1.
Southeast Asian ovalocytosis is now known to be caused
Distal renal tubular acidosis and Southeast Asian ova-
by a mutation of the AE1 (anion exchanger 1) gene, which
locytosis have an intimate biochemical relationship that
codes for band 3, a 911 amino acid protein that is both
has taken over 30 years to unravel. The story starts with
a structural component of the red cell membrane cyto-
the 1968 description of a family with both diseases [1].
skeleton and the chloride-bicarbonate anion-exchanger
In the original report the red cell abnormality was de-
in this membrane (Figs. 2 and 3). Band 3 is the most
scribed as “hereditary elliptocytosis,” though it is now
abundant of red cell membrane proteins, with approxi-
clear that the published blood films showed the ovalo-
mately a million copies of the molecule in each red cell
cytes of SAO, in keeping with the Filipino origin of the
[7–9]. Within the red cell membrane band 3 exists in the
family. The renal disease in this family presented in two
form of a dimer or higher oligomer. The mutation caus-
sisters under the age of 5 with failure to thrive, hyper-
ing SAO is a 27-base deletion of the AE1 gene in chromo-
chloremic acidosis, hypokalemia, rickets and nephro-
some 17 that results in a deletion of the nine band 3 amino
calcinosis, and was thus typical of Type 1 or Classic renal
acids 400-408 inclusive [10–12]. Invariably this mutation
tubular acidosis, nowadays often designated “hypoka-
is accompanied by substitution in band 3 of lysine 56lemic dRTA.” The authors of this original report could
by glutamic acid (K56E), the asymptomatic “Memphis”not suggest any reason why the two diseases should co-
polymorphism that is common in the general healthyexist in the same family, and considered that the associa-
population. The SAO deletion results in a complete loss
of anion transport activity in the mutant band 3 [13].
SAO, as its name implies, is found almost exclusively inKey words: AE1, anion exchanger, gene mutation, distal renal tubular
acidosis, ovalocytosis, spherocytosis. Southeast Asia (Fig. 4), especially the Malay archipelago,
the Philippines, Indonesia and southern Thailand, withReceived for publication October 18, 2001
a prevalence as high as 30% in the Indonesian island ofand in revised form February 15, 2002
Accepted for publication February 15, 2002 Sulawesi and parts of Papua New Guinea [14]. The SAO
erythrocyte is exceptionally rigid, but the abnormality 2002 by the International Society of Nephrology
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Fig. 1. Blood films in hereditary elliptocytosis
(A) and Southeast Asian ovalocytosis (B). In
elliptocytosis the long axis of the cells is often
more than twice the transverse axis, and there
are occasional rod-shaped cells. In SAO the
long axis of the oval cells is usually less than
twice the transverse axis; many erythrocytes
contain a transverse band of pallor (“stomato-
cytes”) or a well-hemoglobinized ridge, and
there are occasional large macrocytes. (Re-
printed from Practical Haematology by J.V. Da-
cie and S.M. Lewis, Figures 7.11 and 7.13, pp
101 and 102, 1995 [5] with permission from the
publisher, Harcourt Churchill Livingstone.)
Fig. 2. Structure of erythrocyte membrane.
(Reprinted from The Inherited Metabolic Dis-
eases by A.J. Grimes and N.C.P. Slater, Figure
14.1, p. 526, 1994 [6], with permission of the
publisher Harcourt Churchill Livingstone.)
does not cause hemolytic anemia, and by itself does not are derived, through the enzymatic action of cytoplasmic
carbonic anhydrase II, from the hydration of carbongive rise to morbidity. SAO is believed to have evolved
dioxide to carbonic acid, which dissociates to form bicar-because these parts of Southeast Asia historically have
bonate and hydrogen ions, the latter being secreted intohad a high incidence of Plasmodium falciparum malaria,
the tubule through the action of an H-ATPase or anagainst which SAO offers clinical protection [15, 16]. In
H/K-ATPase in the luminal (apical) membrane (Fig. 5).this respect SAO resembles sickle-cell disease, the tha-
The bicarbonate generated by this process leaves thelassemias, and glucose-6-phosphate dehydrogenase de-
tubular cell by the bicarbonate/chloride exchanger onficiency, all of which are hereditary conditions that are
the basolateral membrane and enters the blood stream.believed to have evolved in areas affected by P. falci-
Endeavors to discover the molecular basis of familialparum malaria as a result of the protection they provide
dRTA have been directed at the various componentagainst this disease. The clinical impression that SAO is
parts of distal proton secretion: the carbonic anhydrase IImore benign than these other diseases is to some extent
(CA II) within the tubular cytoplasm, the proton pumpsillusory, for in practice SAO is always in the asymptom-
on the luminal membrane (particularly the H-ATPase),atic heterozygous form, the homozygous state apparently
and the anion-exchanger on the basolateral membrane.being so lethal that it does not survive in utero.
RTA due to CA II mutations is a very rare disease that
has more the features of proximal than of distal RTA,
PATHOPHYSIOLOGY OF dRTA in keeping with the wide distribution of CA II through-
The basic fault is generally considered to lie in the out the nephron. The nephrocalcinosis of other forms of
proton-secreting alpha-intercalated cell in the renal col- dRTA is rare in this syndrome, which is characterized
by osteopetrosis and cerebral calcification [18]. Of thelecting duct [17]. In this cell the protons to be secreted
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Fig. 3. Band 3, the erythroid bicarbonate/chloride exchanger. The N-terminal 358 amino acids are not shown. Mutations causing SAO and dRTA
are shown in color. Redrawn from [9], with permission of the publisher, Taylor and Francis, at http://www.tandf.co.uk/Journals.
Fig. 4. Southeast Asia. The area shown covers 5200 miles from west to east and 3400 miles from north to south. Colored arrows represent
individual families with dRTA and a band 3 mutation. The PNG family shown with the A858D mutation also had members with the V850
mutation.
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Fig. 5. Ion pathways involved in proton se-
cretion in the renal collecting duct. The bicar-
bonate/chloride exchanger on the basolateral
membrane is the anion-exchanger number 1
(AE1, band 3) truncated at the N-terminal
by loss of 65 amino acids. CAII is carbonic
anhydrase II. Redrawn from [17], with permis-
sion of the authors and the publisher, Lippin-
cott Williams & Wilkins  2000.
two proton pumps on the luminal membrane, defects of two anion-exchangers are identical except that the renal
isoform is truncated of the 65 N-terminal amino acidsthe H/K-ATPase have not yet been incriminated as
playing a part in familial dRTA, but recent work has that are present in the erythrocytic form [22–24]. This
established the critical role of mutations affecting the observation suggested that AE1 mutations affecting the
H-ATPase in autosomal recessive dRTA. The more transport functions of this ion exchanger might be re-
common form of the disease with sensineural deafness sponsible for both SAO and dRTA, and it was with this
has been shown to be associated with mutations affecting hypothesis in mind that a search for band 3 mutations
the ATP6B1 subunit of this H-ATPase, which also is in subjects with hereditary dRTA was started about eight
expressed in the cochlea and endolymphatic sac of the years ago. The first observations were described in 1996
inner ear [19], providing a good conceptual framework [25], and were rapidly confirmed in several other centers.
for the association of this type of dRTA with hearing
loss. In the less common form of recessive dRTA with
BAND 3 MUTATIONS IN FAMILIAL dRTAnormal hearing, only recently recognized as a separate
In familial dRTA in Western populations (Europe,entity [20], mutations affecting an accessory subunit of
North America and Australia) SAO has not been reported,the H-ATPase, designated ATP6N1B, have been de-
and red cells are morphologically normal. Affected fam-scribed recently [21]. In contrast to the recessive disease,
ily members with the dominant disease were found todRTA has not yet been established to result from a
have AE1 gene mutations [20, 25–29]. In nine of the firstmutation affecting the H-ATPase in any patient with
eleven families studied, the mutation consisted of a sub-the dominant form of the disease.
stitution of the arginine molecule in position 589 of theBy comparison with the energy-dependent proton
band 3 molecule (Fig. 3) usually by histidine, though inpumps on the urinary side of the acid-secreting renal
other families arginine was replaced by cysteine or ser-cell, the chloride/bicarbonate exchanger on the opposite
ine, and two families had mutations affecting other partsside of the cell might seem a less likely candidate for
of the band 3 molecule including the mutant band 3WALTONthe molecular defect of dRTA. However, this anion ex-
described below with an eleven amino acid deletion atchanger is vital to tubular acid excretion, for loss of
the C-terminus of the protein. The search for band 3its function in the presence of continuing hydrogen-ion
secretion by the luminal proton pumps would lead to mutations in familial dRTA was extended to the re-
cessive form of the disease, but none of the familiesexcessive accumulation of bicarbonate within the cell,
with a consequent reduction in the dissociation of car- initially studied, all of Western or Middle-East stock and
with normal red cell morphology, were found to havebonic acid and hence reduced availability of protons for
secretion into the tubular lumen. The particular rele- AEI mutations [20]. Many of these families were later
shown to have mutations affecting the renal H-ATPase,vance of SAO to dRTA lies in the finding that the AE1
gene codes not only for the band 3 in the red cell, but as already described.
Southeast Asia, owing to the prevalence of SAO, shouldalso for the chloride/bicarbonate exchanger on the baso-
lateral membrane of this renal -intercalated cell. The be a fertile area for research into the association of dRTA
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Fig. 6. Family trees of Malaysian family with
dRTA, SAO and G701D mutation (left), and
PNG family with dRTA, SAO and V850
mutation (right). Squares are males, circles
females, solid symbols show dRTA patients,
n.t., not tested. Redrawn from [39], with per-
imssion from the authors, 2000, Biochemical
Journal, 350, p. 43,  the Biochemical Society
at http://www.biochemj.org.
with AE1 mutations. However, dRTA has not been re- to the east, different band 3 mutations were found to be
associated with dRTA in six families in the malariousported particularly frequently from these regions. The ex-
ception has been Thailand. In the northeastern region north coastal areas of the island [39]. Affected family
members all had a mutation causing deletion of valineof this country, where SAO is uncommon, dRTA is suf-
ficiently common to be described as “endemic” [30]. In in the 850 position (V850), which was usually present
as a compound heterozygote with the SAO deletion,earlier Thai studies no association between SAO and
dRTA was remarked; the prevalence of dRTA was at- though in one affected child it was homozygous and in
another it formed a compound heterozygote with a sec-tributed either to chronic dietary deficiency of potassium
[31–33], or environmental pollution with vanadium [30, 34], ond mutation involving substitution of aspartic acid for
alanine in the 858 position. This latter A858D mutationin keeping with in vitro studies showing inhibition of
distal nephron H/K-ATPase by vanadium [35] and the was described as dominant, unlike the G701D andV850
mutations, for in heterozygous form it was associatedobservation that vanadium toxicity in rats can lead to a
state similar to human dRTA [36]. However, more recent with impaired ability to acidify the urine but no acidosis
(incomplete syndrome of dRTA) in two families in Ma-genetic studies of dRTA patients in northeast Thailand,
who do not have SAO, has revealed six families with mis- laysia and Papua New Guinea.
Figure 4 shows the location in Southeast Asia of thesense AE1 mutations affecting band 3 residue 701, with
substitution of glycine by aspartic acid (abstract; Vasu- individual dRTA families so far shown to have band 3
mutations. Figure 6, with two family trees of dRTA/vattakul et al, J Am Soc Nephrol 11:415A, 2000) [37].
This G701D mutation is recessive, with dRTA affecting SAO patients, shows how the presence of a compound
heterozygote of SAO with a second band 3 mutationonly positive family members who are homozygous for
the defect. In mainland Malaysia and the part of southern (G701D in the Malaysian, and V850 in the PNG family)
leads to children with the association of dRTA and SAO.Thailand that extends into the Malay peninsula, the iden-
tical mutation has been found in a further four dRTA The clinical phenotype of the Malaysian family—two
siblings with dRTA/SAO, one parent with SAO and thefamilies, but here the G701D mutation runs as a com-
pound heterozygote with the SAO mutation on the other other apparently healthy—is the same as the Filipino
family originally described in 1968 [1], though the iden-allele [38, 39]. Relatives with either the G701D or the
SAO mutation, but not both, were found to acidify their tity of the putative second band 3 mutation in that family
is unknown.urine normally, as were unrelated subjects with SAO
alone. In relation to dRTA, the SAO mutation thus ap- The few reports available thus far show that the renal
phenotype of familial dRTA, whether caused by band 3pears to behave as a recessive mutation, causing the
renal disease only when accompanied by another band mutations or mutations affecting the proton pump sub-
units ATP6B1 or ATP6N1B, closely corresponds with3 mutation in the opposite allele; homozygous SAO has
not yet been reported, but it is likely that such individ- dRTA as originally established in the West [40], usually
presenting in childhood with failure to thrive, systemicuals would have dRTA if they survived intrauterine life.
Among other defects, these homozygotes would com- acidosis, hypokalemia and nephrocalcinosis, and fre-
quently accompanied by rickets [19–21, 26, 39]. The clini-pletely lack AE1-associated anion transport activity in
their red cells and kidneys, and their red cells would be cal features vary widely, even within the same family.
There is an impression that the dominant disease usu-expected to have marked changes in shape and mechani-
cal characteristics which could alter their properties in ally takes a milder form, presenting in late childhood or
young adults, whereas the recessive disease commonlythe circulation.
In Papua New Guinea (PNG), more than 3000 miles presents under the age of four years with the same clini-
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Table 1. Recognized genetic varieties of familiar distal renal tubular acidosis (dRTA)
Classification of dRTA Geographical location Mutation Clinical presentation References
Autosomal dominant Usually Western, probably AE1 (chromosome 17): Late childhood and [20, 25–29]
worldwide R589H, R589C, R589S, young adults
S613P, A858D, R901-stop
Autosomal recessive
with sensineural deafness Western, Middle East ATP6B1 (chromosome 2): Usually infants [19]
15 different mutations
with normal hearing Middle East ATP6N1B (chromosome 7): Usually infants [21]
8 different mutations
Southeast Asia AE1 (chromosome 17): Usually infants
G701D,  V850; often
compound heterozygotes
with SAO
cal features in more severe form (Table 1). However, acidification in six families, but impaired acid excretion
these apparent differences may result from differences (incomplete dRTA syndrome) in two affected members
in case selection, for the younger patients with recessive of a seventh family with a heterozygous band 3 mutation
disease have been reported from developing countries (band 3PIBRAM) involving deletion of the C-terminal por-
where mildly affected and older patients might well es- tion of the molecule including all but the first three trans-
cape medical attention. Apart from these possible dif- membrane domains [43]. A catastrophic band 3 mutation
ferences in age of presentation and clinical severity, the has recently been reported from Portugal [44], a valine
only clinical differences between the several genotypes for methionine 488 substitution (band 3COIMBRA) that in
causing the disease are non-renal criteria such as ethnic homozygous form led to a barely viable infant with com-
origin, family history, red cell findings and hearing loss. plete absence of erythrocytic band 3, a blood film show-
Familial dRTA thus behaves like some other heredi- ing spherocytosis with bizarre red cell elongations, se-
tary forms of renal tubular disease, such as Bartter’s vere hemolytic anemia and complete dRTA, including
syndrome and nephrogenic diabetes insipidus, in that nephrocalcinosis shown within the first year of life.
the same renal phenotype may result from more than
one genotype.
DISTRIBUTION OF FAMILIALHemolytic anemia is not a feature of SAO by itself,
dRTA WORLDWIDEor of the dominant band 3 mutations causing dRTA,
Table 1 summarizes current findings regarding the mo-but is a feature of children who are homozygous for the
lecular basis of the main forms of familial dRTA andG701D mutation or have dRTA with the compound
the geographical and ethnic distribution of the resultantheterozygotes G701D/SAO, V850/SAO, A858D/SAO
disease. The data are provisional and likely to be radi-and V850/A858D [39]. Hemolysis has not been re-
cally changed as further discoveries are made. Autosomalported in recessive dRTA caused by proton pump muta-
dominant dRTA, the result of an AE1 mutation, is showntions, but is not to be expected in these syndromes owing
as probably worldwide in distribution, and usually theto the lack of band 3 abnormalities that would damage
result of a mutation affecting residue 589 in band 3, butred cell integrity.
except for the A858D mutation found in two families inBand 3 mutations are involved not only in the ovalo-
Southeast Asia, to date only Western families have beencytosis of SAO, but also in many cases of hereditary
studied genetically. Autosomal recessive dRTA causedspherocytosis (HS), which unlike SAO is associated with
by H-ATPase mutations has been predominantly theincreased osmotic fragility of erythrocytes and hemolytic
result of intermarriage in Middle Eastern countries, andanemia. The basic fault in HS is a defect in red cell
this is especially so in the disease with intact hearing andmembrane surface area; the condition is genetically het-
ATP6N1B mutations, of whom all nine reported familieserogenous and associated with several membrane disor-
have been from the Middle East, and all but one the prod-ders, including defects in band 3, spectrin and ankyrin.
uct of consanguineous unions [21]. Autosomal recessiveOver 40 different band 3 mutations have been reported
dRTA associated with AE1 mutations has been restrictedin HS, affecting both cytoplasmic and membrane parts
to families of Southeast Asian origin, in whom it mayof the molecule, the majority of them missense mutations
be the result of a homozygous AE1 mutation but moreor single amino acid deletions or insertions [41, 42]. With
often results from a compound heterozygote of SAOrare exceptions, affected individuals do not usually have
with another AE1 mutation. The countries affected bythe dRTA phenotype. A study of seven unrelated fami-
lies with HS and band 3 defects showed normal urinary SAO have a total population of over four hundred mil-
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lion, but are relatively undeveloped and medically under- abnormal erythrocyte membrane of SAO [15]. No data
are currently available to suggest whether the G701Dresourced, so the prevalence of this form of dRTA is
likely to have been underestimated (Fig. 4). Mutations and V850 mutations have this effect, and this is a possi-
ble subject for future study.of the collecting duct H/K-ATPase causing dRTA,
either dominant or recessive, and mutations of the H-
ATPase causing the dominant disease, have not yet
MOLECULAR BASIS OF RECESSIVE dRTA
been reported.
WITH BAND 3 MUTATIONS
Recessive dRTA appears to result from the absence
EVOLUTION OF BAND 3 DEFECTS or a very marked deficiency of chloride-bicarbonate ex-
WITH dRTA change activity in the basolateral membrane of the kid-
ney intercalated cell. In the case of the G701D muta-The band 3 mutations demonstrated so far in South-
east Asian dRTA families (G701D, V850 and A858D) tion this occurs because the mutant protein is totally
dependent on the presence of glycophorin A (GPA) foroccupy different sites in the band 3 molecule from those
found in dRTA patients in the West. Furthermore, the its movement to the cell surface. GPA is a glycosylated
protein that is associated with band 3 and has a singleG701D and V850 mutations found in Southeast Asia
are unlike those found in the West in being recessive span across the erythrocyte membrane (Fig. 2). Expres-
sion in Xenopus oocytes [37, 39, 46] demonstrated thatrather than dominant. What is the explanation for these
differences? In the Western disease nearly all the rele- GPA completely rescues the cell surface movement of
the G701D mutant band 3 to normal levels. This con-vant mutations consist of single amino acid substitutions
of arginine 589, usually with histidine but also with cyste- trasts with normal band 3, which moves to the cell surface
even in the absence of GPA, although GPA furtherine and serine. In two Western families of Irish origin
with the histidine substitution, no founder effect could enhances this movement [47]. Red cells contain GPA
but GPA is absent from the kidney, hence individualsbe shown by haplotype analysis [26]. The high frequency
of mutations at Arginine 589 to histidine and cysteine homozygous for the G701D mutation have normal levels
of band 3 in their red cells [37, 39]. It is proposed that,most likely results from the recognized propensity of
cytosine in CG sequences to undergo mutation to thy- in homozygotes, the mutant G701D protein does not
reach the basolateral membrane of the intercalated cell,mine [45]. In Southeast Asia the principal mutations
reported to date in dRTA (SAO 400-408, G701D and but is turned over within the cell [37, 39, 46]. In SAO/
G701D compound heterozygotes, the SAO protein isV850) are recessive in relation to dRTA. There is evi-
dence of a founder effect with all three mutations: In presumed to reach the cell surface, but since it is inactive
in anion transport [13], it acts as if it were a band 3 nullSAO the K56E Memphis polymorphism is invariably
found, suggesting a common origin to both mutations in allele. The recessive V850 mutation behaves differently;
expression studies in Xenopus oocytes show that it isthe past. Likewise, the G701D mutation is accompanied
by a threonine for methionine substitution in the 31 expressed very poorly at the cell surface in the absence
of GPA, and GPA only partially rescues the cell surfaceposition, M31T [37, 39]. This latter mutation is unlikely
to be related to the renal disease as it is not expressed movement of the V850 mutant [39]. In this case the dis-
ease probably results from inadequate anion exchangein the renal isoform, but suggests a founder effect, which
would be in keeping with the continuity of the land mass activity in renal tubular intercalated cells as a result of
a much decreased level of band 3 [39].where these mutations have been found (Fig. 4). Finally,
in the case of the V850 mutation, the close geographi- The presence of the SAO mutation clearly has a dele-
terious effect on the function of the normal allele, orcal clustering of affected kindreds to the north coast of
Papua New Guinea is suggestive of a founder effect. other mutant allele in compound heterozygotes. These
effects show most clearly in the altered hematology andThe SAO, G701D andV850 mutations carry no mor-
bidity in their heterozygous form, and the suggestion of a red cell properties in these individuals. It has already
been noted that the red cells of simple SAO hetero-founder effect to each mutation implies that the relevant
heterozygotes have had some survival advantage in past zygotes are more rigid than normal, although these in-
dividuals do not have anemia. In addition, the spe-generations, leading to the wider distribution of the mu-
tation. In the case of SAO this survival advantage is pro- cific anion transport activity per band 3 molecule of the
normal protein in SAO red cells is reduced to 75% oftection against clinical effects of P. falciparum malaria,
as already mentioned. Parasitized normal erythrocytes that in normal red cells [13, 39]. Even more striking
changes occur in the red cells of individuals who arebecome unusually sticky, leading to the occlusion of cap-
illaries that characterizes cerebral malaria. The sug- compound heterozygotes of SAO and dRTA mutations
[39]. Compound heterozygotes of SAO with the G701Dgested mechanism for protection in SAO individuals is
that this stickiness (“cytoadherence”) is reduced by the and A858D mutations had red cell membrane rigidity
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that was markedly higher than even the simple SAO perimental verification of the mechanisms involved will
be needed for each of the mutants.heterozygotes in the same families. The specific anion
Recent studies of the expression of a band 3 mutanttransport activity per band 3 molecule in the red cells
(band 3WALTON) expressed in red cells and renal tubularof compound heterozygotes of SAO and the A858D or
cells suggest a mechanism for the dominant dRTA inV850 mutations was reduced to 17% and 55%, re-
this case [48]. In band 3WALTON the eleven C-terminalspectively, of the activity of the normal protein, al-
amino acids 901-911 are deleted. The mutant protein isthough the mutant proteins had much higher activity in
expressed in red cells but at a reduced level, and trans-simple heterozygotes. Finally, compound heterozygotes
port studies of the red cells and the protein expressedof SAO with the G701D, V850 or A858D mutations
in Xenopus oocytes have shown normal anion transportall showed anemia of variable degree, but there was no
activity. In contrast, although normal kidney band 3 wasevidence of this in simple heterozygotes of these dRTA
expressed at the cell surface in a kidney cell line, themutations in the same families [39]. These effects clearly
Walton kidney band 3 was retained within the cytoplasmdemonstrate that the band 3 SAO mutation alters the
of these cells and did not migrate to the cell membrane.structure of these dRTA mutant band 3 alleles, usually
Band 3WALTON is clearly targeted differently in erythro-in a detrimental fashion. These changes in properties
cytes and kidney cells, and the presence of the normalvery likely occur within band 3 hetero-oligomers, as a
band 3 C-terminal tail is required for movement to theresult of interactions between the SAO protein and the
cell surface of kidney cells. It is likely that dominantdRTA mutant protein that alter the structural and func-
dRTA arises because the mutant protein inhibits thetional characteristics of the dRTA protein. Evidence for
movement of normal band 3 to the cell surface. Thus, theinteractions of this type also comes from co-expression
association of the normal and mutant protein in band 3studies in Xenopus oocytes [39]. Similar interactions with
hetero-oligomers causes the intracellular retention of thethe SAO protein almost certainly occur in the kidney
normal band 3 along with the abnormal protein.and are likely to modify the functional properties of the
The above mechanism also provides an explanationdRTA mutant proteins in intercalated cells.
for the puzzling observation that band 3 mutations that
cause dominant hereditary spherocytosis (HS) almost
invariably do not cause dominant dRTA, and dominantMOLECULAR BASIS OF DOMINANT dRTA
dRTA band 3 mutations do not give rise to HS. Band 3WITH BAND 3 MUTATIONS
mutations causing HS lead to a significant decrease inThe usual band 3 mutation in this form of RTA is a sin-
the amount of erythrocyte band 3, which destabilizes andgle amino acid substitution of arginine 589. Here dRTA
reduces the area of the red cell membrane. In dominantclearly does not result simply from a reduction in the
dRTA the mutant proteins are present at substantiallyanion exchanger activity in the kidney, since the presence
normal levels in the affected red cells, and therefore HSof the anion transport-inactive SAO allele or the other
does not result. Most dominant AE1 mutations causingtransport-inactive mutant alleles found in hereditary
HS either result in an unstable mRNA (and thereforespherocytosis (discussed below) that can decrease red
no protein is synthesized) or the protein is misfoldedcell anion exchange by more than 50%, are not normally
and not incorporated into the erythrocyte membraneassociated with dRTA. In addition, most of the dominant
[41]. The latter HS mutations are probably recognizeddRTA band 3 mutant proteins have almost normal anion
and eliminated by the endoplasmic reticulum-associated
transport activity [26]. Several possible mechanisms for
degradation (ERAD) and quality control system [49]
dominant dRTA have been proposed [26]: interactions
before they have an opportunity to form hetero-oligo-
between the normal and mutant proteins in band 3 oligo- mers that result in the intracellular retention or mistar-
mers that alter the targeting properties of the normal geting of normal band 3, which is required to cause
protein, either by preventing the movement of the nor- dominant dRTA. The rarity of dRTA associated with
mal and mutant proteins to the cell surface or sending HS suggests that the association of normal and mutant
them to an inappropriate membrane; mistargeting of the band 3 proteins in hetero-oligomers may be a general
mutant protein to the apical membrane of the interca- requirement for the manifestation of dominant dRTA.
lated cell, thus neutralizing the proton gradient induced
by the H-ATPase by allowing the exit of bicarbonate
BAND 3 IN NON-FAMILIAL dRTAwith the protons pumped into the urinary fluid; or the
mutant band 3 may form a membrane channel or leak This review is primarily concerned with familial
in the plasma membrane of the intercalated cells that dRTA, but the band 3 bicarbonate/chloride exchanger
would dissipate the ionic gradients across the cell that are also may be involved in autoimmune dRTA, the other
required for the net secretion of acid. Different dominant common form of primary dRTA, which is clinically asso-
ciated with extrarenal autoimmune disease, particularlydRTA mutations may well act in different ways and ex-
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